RTI SURGICAL, INC. (NASDAQ:RTIX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

RTI SURGICAL, INC. (NASDAQ:RTIX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Story continues below

Item5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

(e) Compensatory Arrangements of Certain Officers

2017 Salaries and Bonus Targets. On March14, 2017, the
Compensation Committee of the Board of Directors of RTI Surgical,
Inc. (the Company) approved 2017 salaries and bonus targets
(expressed as a percentage of salary) for each of the Companys
executive officers. The table below sets forth this information:

Name

Office

2017 Salary Bonus Target

Camille Farhat

President and Chief Executive Officer

$ 635,000 %

Robert P. Jordheim

Executive Vice President and Chief Financial Officer

$ 374,286 %

Roger W. Rose

President, RTI Donor Services, Executive Vice President

$ 350,115 %

Kevin D. Brandt

Executive Vice President, Chief Commercial Officer Domestic
Direct

$ 337,366 %

John N. Varela

Executive Vice President Global Operations

$ 337,428 %

At a subsequent meeting, the Compensation Committee will set the
cash bonus performance criteria for each of the Companys
executive officers and also approve equity awards to certain
executive officers to the 2015 Incentive Compensation Plan. At
such time, the Company will file an amendment to this Current
Report on Form 8-K
to disclose such information.


About RTI SURGICAL, INC. (NASDAQ:RTIX)

RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes, and manufactures metal and synthetic implants for distribution to hospitals and surgeons. The Company distributes its implants and services in approximately 50 states and in over 45 countries across the world.

RTI SURGICAL, INC. (NASDAQ:RTIX) Recent Trading Information

RTI SURGICAL, INC. (NASDAQ:RTIX) closed its last trading session down -0.11 at 3.74 with 370,111 shares trading hands.

An ad to help with our costs